Quest Diagnostics Incorporated (DGX)
Automate Your Wheel Strategy on DGX
With Tiblio's Option Bot, you can configure your own wheel strategy including DGX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol DGX
- Rev/Share 93.9464
- Book/Share 65.5893
- PB 2.8468
- Debt/Equity 0.8832
- CurrentRatio 1.086
- ROIC 0.0776
- MktCap 20544121560.0
- FreeCF/Share 10.9286
- PFCF 16.7844
- PE 21.6824
- Debt/Assets 0.3998
- DivYield 0.0169
- ROE 0.1368
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 5
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Initiation | DGX | Redburn Atlantic | -- | Buy | -- | $195 | April 2, 2025 |
| Downgrade | DGX | Citigroup | Buy | Neutral | -- | $185 | March 4, 2025 |
| Upgrade | DGX | Leerink Partners | Market Perform | Outperform | $169 | $174 | Jan. 6, 2025 |
| Upgrade | DGX | Morgan Stanley | Equal Weight | Overweight | $145 | $172 | Dec. 17, 2024 |
| Resumed | DGX | Jefferies | -- | Buy | $175 | $185 | Dec. 10, 2024 |
| Upgrade | DGX | Robert W. Baird | Neutral | Outperform | $157 | $182 | Oct. 23, 2024 |
| Resumed | DGX | Evercore ISI | -- | In-line | -- | $165 | Aug. 28, 2024 |
News
Why Is Quest Diagnostics (DGX) Up 8.2% Since Last Earnings Report?
Published: August 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock?
Read More
Should Quest Diagnostics Stock Be in Your Portfolio Right Now?
Published: August 21, 2025 by: Zacks Investment Research
Sentiment: Negative
DGX drives growth with advanced diagnostics, acquisitions and cost savings, but rising debt and macro risks weigh on its outlook.
Read More
Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference
Published: August 15, 2025 by: PRNewsWire
Sentiment: Neutral
SECAUCUS, N.J. , Aug. 15, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends during the Baird 2025 Global Healthcare Conference in New York City on Wednesday, September 10, 2025, at 10:50 a.m.
Read More
Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock
Published: August 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Quest Diagnostics Incorporated (DGX) Q2 2025 Earnings Call Transcript
Published: July 22, 2025 by: Seeking Alpha
Sentiment: Neutral
Quest Diagnostics Incorporated (NYSE:DGX ) Q2 2025 Earnings Conference Call July 22, 2025 8:30 AM ET Company Participants James E. Davis - Chairman, CEO & President Sam A.
Read More
Quest Diagnostics Beats Q2 Earnings & Revenue Estimates, Stock Rises
Published: July 22, 2025 by: Zacks Investment Research
Sentiment: Positive
DGX tops Q2 estimates with 15.2% revenue growth and a strong EPS beat, lifting the stock 3.2% in pre-market trading.
Read More
DGX Q2 Earnings Preview: Will Advanced Diagnostics Lead Performance?
Published: July 21, 2025 by: Zacks Investment Research
Sentiment: Neutral
Quest Diagnostics' Q2 results may get a lift from Advanced Diagnostics, new health plan deals and recent acquisitions.
Read More
Will Quest Diagnostics (DGX) Beat Estimates Again in Its Next Earnings Report?
Published: July 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Quest Diagnostics (DGX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy?
Published: July 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Quest Diagnostics Stock Climbs 27.3% in a Year: What's Fueling It?
Published: July 07, 2025 by: Zacks Investment Research
Sentiment: Positive
DGX stock surges 27.3% in a year, fueled by Advanced Diagnostics, key acquisitions and expanding health plan ties.
Read More
4 Stocks to Watch in a Rapidly Shifting Outpatient Home Health Space
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Positive
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, EHC, DVA and PNTG are well-poised to gain.
Read More
Is Quest Diagnostics Stock a Smart Pick for Your Portfolio Now?
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Negative
DGX rides on double-digit diagnostics growth and a wave of strategic acquisitions despite rising debt and policy headwinds.
Read More
Quest Diagnostics (DGX) Upgraded to Buy: Here's What You Should Know
Published: June 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Quest Diagnostics (DGX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Read More
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
Published: June 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Quest Diagnostics Releases 2024 Corporate Responsibility Report
Published: June 25, 2025 by: PRNewsWire
Sentiment: Neutral
SECAUCUS, N.J. , June 25, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today published its 2024 Corporate Responsibility Report.
Read More
Quest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025
Published: June 23, 2025 by: PRNewsWire
Sentiment: Neutral
SECAUCUS, N.J. , June 23, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report second quarter 2025 financial results on Tuesday, July 22, 2025, before the market opens.
Read More
DGX Stock Up on New Blood Test Development Deal With MD Anderson
Published: June 17, 2025 by: Zacks Investment Research
Sentiment: Neutral
DGX stock rises on a new partnership with MD Anderson to develop a blood test targeting multiple cancer risks.
Read More
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
Published: June 02, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick?
Published: May 27, 2025 by: Zacks Investment Research
Sentiment: Positive
With women's health increasingly becoming a global priority, investors are actively targeting companies operating in this space to boost their portfolios. Research and Markets projects the women's health diagnostics market to expand at a compound annual rate of 9.25% through 2030, driven by technological advancements, increasing healthcare expenditures, and initiatives for early detection of women-specific conditions like reproductive health issues, breast cancer, osteoporosis and more.
Read More
What's Driving Quest Diagnostics Stock's 25.6% Rally in a Year?
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive
DGX has shown notable strength in the past year, driven by robust core performance and contributions from acquisitions.
Read More
Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference
Published: May 16, 2025 by: PRNewsWire
Sentiment: Neutral
SECAUCUS, N.J. , May 16, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends during a presentation at the William Blair 45th Annual Growth Stock Conference in Chicago on Tuesday, June 3, 2025, at 11:00 a.m.
Read More
Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock
Published: May 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Take the Zacks Approach to Beat the Markets: ADMA Biologics, Limbach, Quest Diagnostics in Focus
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Neutral
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Read More
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings
Published: April 23, 2025 by: Benzinga
Sentiment: Positive
Quest Diagnostics Incorporated DGX posted better-than-expected first-quarter earnings on Tuesday.
Read More
Quest Diagnostics Incorporated (DGX) Q1 2025 Earnings Call Transcript
Published: April 22, 2025 by: Seeking Alpha
Sentiment: Neutral
Quest Diagnostics Incorporated (NYSE:DGX ) Q1 2025 Results Conference Call April 22, 2025 8:30 AM ET Company Participants Shawn Bevec - Vice President of Investor Relations Jim Davis - Chairman, Chief Executive Officer, President Sam Samad - Chief Financial Officer Conference Call Participants Luke Sergott - Barclays Kevin Caliendo - UBS Patrick Donnelly - Citi Elizabeth Anderson - Evercore ISI Michael Cherny - Leerink Partners Pito Chickering - Deutsche Bank Noah Kava - Jefferies David Westenberg - Piper Sandler Michael Ryskin - Bank of America Andrew Brackmann - William Blair Jack Meehan - Nephron Research Erin Wright - Morgan Stanley …
Read More
Quest Diagnostics Q1 Earnings & Revenues Top Estimates, Stock Up
Published: April 22, 2025 by: Zacks Investment Research
Sentiment: Positive
DGX delivers solid top-line growth in the first quarter of 2025.
Read More
Quest Diagnostics (DGX) Q1 Earnings and Revenues Beat Estimates
Published: April 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Quest Diagnostics (DGX) came out with quarterly earnings of $2.21 per share, beating the Zacks Consensus Estimate of $2.15 per share. This compares to earnings of $2.04 per share a year ago.
Read More
Quest beats quarterly profit estimates on strong demand for diagnostic tests
Published: April 22, 2025 by: Reuters
Sentiment: Positive
Laboratory operator Quest Diagnostics beat Wall Street estimates for first-quarter profit on Tuesday, helped by robust demand for its diagnostic tests.
Read More
8 Upcoming Dividend Increases During Volatile Times
Published: April 04, 2025 by: Seeking Alpha
Sentiment: Positive
8 Upcoming Dividend Increases During Volatile Times
Read More
About Quest Diagnostics Incorporated (DGX)
- IPO Date 1996-12-17
- Website https://www.questdiagnostics.com
- Industry Medical - Diagnostics & Research
- CEO James E. Davis
- Employees 55000